Levonorgestrel/Ethinylestradiol Chemical Farma 150/30 microgram, filmomhulde tabletten

국가: 네덜란드

언어: 네덜란드어

출처: CBG-MEB (College ter Beoordeling van Geneesmiddelen)

지금 구매하세요

Download 환자 정보 전단 (PIL)
22-05-2019
Download 제품 특성 요약 (SPC)
22-05-2019

유효 성분:

ETHINYLESTRADIOL ; LEVONORGESTREL

제공처:

Laboratoires Chemical Farma

ATC 코드:

G03AA07

INN (국제 이름):

ETHINYL ESTRADIOL ; LEVONORGESTREL

약제 형태:

Filmomhulde tablet

구성:

CROSPOVIDON (E 1202) ; IJZEROXIDE GEEL (E 172) ; LACTOSE 1-WATER ; MACROGOL 3350 ; MAGNESIUMSTEARAAT (E 470b) ; POLYVINYLALCOHOL, GEDEELTELIJK GEHYDROLYSEERD (E1203) ; POVIDON K 30 (E 1201) ; TALK (E 553 B) ; TITAANDIOXIDE (E 171),

관리 경로:

Oraal gebruik

치료 영역:

Levonorgestrel And Ethinylestradiol

제품 요약:

Hulpstoffen: CROSPOVIDON (E 1202); IJZEROXIDE GEEL (E 172); LACTOSE 1-WATER; MACROGOL 3350; MAGNESIUMSTEARAAT (E 470b); POLYVINYLALCOHOL, GEDEELTELIJK GEHYDROLYSEERD (E1203); POVIDON K 30 (E 1201); TALK (E 553 B); TITAANDIOXIDE (E 171);

승인 날짜:

2013-10-24

환자 정보 전단

                                1
PACKAGE LEAFLET: INFORMATION FOR THE USER
LEVONORGESTREL/ETHINYLESTRADIOL CHEMICAL FARMA 150/30 MICROGRAM,
FILMOMHULDE TABLETTEN
Levonorgestrel / Ethinylestradiol
IMPORTANT THINGS TO KNOW ABOUT COMBINED HORMONAL CONTRACEPTIVES
(CHCS):

They are one of the most reliable reversible methods of contraception
if used correctly

They slightly increase the risk of having a blood clot in the veins
and arteries, especially in the first year
or when restarting a combined hormonal contraceptive following a break
of 4 or more weeks

Please be alert and see your doctor if you think you may have symptoms
of a blood clot (see section 2
“Blood clots”)
WHAT IS IN THIS LEAFLET
1.
What Levonorgestrel/Ethinylestradiol Chemical Farma 150/30 microgram,
filmomhulde tabletten is and
what it is used for
2.
What you need to know before you take Levonorgestrel/Ethinylestradiol
Chemical Farma 150/30
microgram, filmomhulde tabletten
3.
How to take Levonorgestrel/Ethinylestradiol Chemical Farma 150/30
microgram, filmomhulde tabletten
4.
Possible side effects
5.
How to store Levonorgestrel/Ethinylestradiol Chemical Farma 150/30
microgram, filmomhulde tabletten
6.
Contents of the pack and other information
1.
WHAT LEVONORGESTREL/ETHINYLESTRADIOL CHEMICAL FARMA 150/30 MICROGRAM,
FILMOMHULDE TABLETTEN IS
AND WHAT IT IS USED FOR

Levonorgestrel/Ethinylestradiol Chemical Farma 150/30 microgram,
filmomhulde tabletten is a
contraceptive pill and it is used to prevent pregnancy.
•
Each of the 21 yellow tablets contains a small amount of two different
female hormones, namely
levonorgestrel and ethinylestradiol.
•
The 7 white tablets contain no active substances and are also called
placebo tablets.

Contraceptive pills that contain two hormones are called
“combination” pills.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE LEVONORGESTREL/ETHINYLESTRADIOL
CHEMICAL FARMA 150/30
MICROGRAM, FILMOMHULDE TABLETTEN
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.

                                
                                전체 문서 읽기
                                
                            

제품 특성 요약

                                SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Levonorgestrel/Ethinylestradiol Chemical Farma 150/30 microgram,
filmomhulde tabletten
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
21 YELLOW FILM-COATED TABLETS (ACTIVE TABLETS):
0.15 mg levonorgestrel and 0.03 mg ethinylestradiol
Excipients with known effect:Each tablet contains 84.32 mg of lactose
monohydrate
7 WHITE PLACEBO (INACTIVE) FILM-COATED TABLETS:
The tablet do not contain active substances
Excipients with known effect: Each tablet contains 89.50 mg of lactose
anhydrous
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film-coated tablet.
Active tablet: Yellow, round, with a diameter of 6 mm and thickness
less than 4 mm approximately.
Placebo tablet: White, round, with a diameter of 6 mm and thickness of
3 - 4 mm approximately.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Oral Contraception.
The decision to prescribe Levonorgestrel/Ethinylestradiol Chemical
Farma 150/30 microgram should
take into consideration the individual woman's current risk factors,
particularly those for venous
thromboembolism (VTE), and how the risk of VTE with
Levonorgestrel/Ethinylestradiol Chemical
Farma 150/30 microgram compares with other combined hormonal
contraceptives (CHCs) (see sections
4.3 and 4.4).
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
_Method of administration_
Oral use
_Posology_
How to take Levonorgestrel/Ethinylestradiol Chemical Farma 150/30
microgram
The tablets must be taken every day at about the same time, if
necessary with a little in the order
shown on the blister pack. One tablet is to be taken daily for 28
consecutive days. Each subsequent pack
is started
after a 7-day placebo-tablet-intake interval, during which time a
withdrawal bleed usually
occurs. This usually starts on day 2-3 after the last active tablet
and may not have finished before
the next pack is started.
How to start Levonorgestrel/Ethinylestradiol Chemical Farma 150/30
microgram

No preceding hormonal contraceptive use [in the past mon
                                
                                전체 문서 읽기
                                
                            

다른 언어로 된 문서

환자 정보 전단 환자 정보 전단 영어 26-07-2017
제품 특성 요약 제품 특성 요약 영어 26-07-2017